Exane Derivatives Davita Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Davita Inc. stock. As of the latest transaction made, Exane Derivatives holds 2 shares of DVA stock, worth $322. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$322
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DVA
# of Institutions
662Shares Held
74.4MCall Options Held
1.41MPut Options Held
1.82M-
Warren Buffett Berkshire Hathaway Inc | Omaha, Ne36.1MShares$5.83 Billion2.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.39MShares$869 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.94MShares$798 Million0.02% of portfolio
-
State Street Corp Boston, MA2.41MShares$389 Million0.02% of portfolio
-
Morgan Stanley New York, NY1.43MShares$230 Million0.02% of portfolio
About DAVITA INC.
- Ticker DVA
- Exchange NYSE
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 91,300,000
- Market Cap $14.7B
- Description
- DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...